Cited by 22Chronic Lymphocytic Leukemia ResearchPI3K/AKT/mTOR signaling in cancerAcute Lymphoblastic Leukemia research

A targeted treatment with off-target risks

Fruman, David A., O'Brien, Susan·2017·Nature

Integrity signals

Registry

Crossref · 10.1038/nature21504

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Off-target effects limit the use of genome editing tools, as gene transfer between engineered bacteria and gut microbiota cannot be artificially controlled.

    “Off-target effects limit the use of genome editing tools, as gene transfer between engineered bacteria and gut microbiota cannot be artificially controlled.17”

The citation lists haven’t been fetched yet

References 13 · Cited by 22

Authors
Fruman, D. A., & O'Brien, S.
Affiliations
University of California, Irvine (US)
Corresponding author
Fruman, David A.
Venue
Nature
Published
2017-02
Volume
542
Issue
7642
Pages
424-425
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2587923427
Cited by
22
References
13
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 6 · 2017: 1
FWCI
1.69
Type
journal article
Language
en
Open access
closed
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Topics
  • Health Sciences › Medicine › Genetics › Chronic Lymphocytic Leukemia Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Acute Lymphoblastic Leukemia research
Keywords
PI3Kδ inhibitor, activation-induced cytidine deaminase, off-target effects, genomic instability, chronic lymphocytic leukemia, B-cell malignancies, DNA recombination, targeted cancer therapy
MeSH terms
Humans, Neoplasms, Risk

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review